Merck Overview

  • Status
  • Public
  • Employees
  • 58,077
Employees
  • Stock Symbol
  • MRK
Stock Symbol
  • Investments
  • 72
  • Share Price
  • $179.56
  • (As of Monday Closing)

Merck General Information

Description

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In its performance materials segment, the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Specialty Chemicals
Stock Exchange
ETR
Primary Office
  • Frankfurter Straße 250
  • 64293 Darmstadt
  • Germany
+49 06151 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$179.56 $180.91 $83.54 - $182.36 $78.1B 435M 477K $4.81

Merck Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 77,736,444 59,166,046 56,639,343 58,961,749
Revenue 19,383,038 18,081,272 17,507,464 16,371,756
EBITDA 5,486,843 4,571,812 4,173,895 4,761,421
Net Income 2,091,985 1,477,667 3,981,544 2,937,826
Total Assets 50,755,503 49,075,858 42,196,294 42,734,602
Total Debt 16,037,570 14,695,537 10,072,066 12,847,614
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Merck Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck‘s full profile, request access.

Request a free trial

Merck Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segm
Drug Discovery
Darmstadt, Germany
58,077 As of 2020
00000000

00000000

gna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000 00000000
Somerset, NJ
00000 As of 0000
00.000
00000000 00.000

00000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat no
000000000 000000000
Port Washington, NY
000 As of 0000
0000000000.
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Merck Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Catalent Formerly PE-Backed Somerset, NJ 00000 00.000 00000000 00.000
00000 Corporation Port Washington, NY 000 0000000000.
00000 Corporation Leverkusen, Germany 000000 00.00 000000000 00.00
00000000 Corporation Basel, Switzerland 000000 000000000000
000000000000000 Corporation Brentford, United Kingdom 00000 00000000000
You’re viewing 5 of 40 competitors. Get the full list »

Merck Executive Team (44)

Name Title Board Seat Contact Info
Stephan Oschmann Ph.D Chairman of the Executive Board & Chief Executive Officer
Roger Perlmutter President
Marcus Kuhnert Ph.D Member of the Executive Board & Chief Financial Officer
Kai Beckmann Ph.D Chief Administration Officer & Member of the Executive Board
Aatraye Almast Inhouse Consulting
You’re viewing 5 of 44 executive team members. Get the full list »

Merck Board Members (9)

Name Representing Role Since
00000 000000 Self Vice Chairman of Executive Board & Deputy CEO 000 0000
00000 00000000 Self Board Member & Chief Executive Officer, Life Science & Performance Materials 000 0000
000000000 00000 00.0 Merck Chairman 000 0000
000 00000000 00.0 Merck Chief Administration Officer & Member of the Executive Board 000 0000
000000 0000000 00.0 Merck Member of the Executive Board & Chief Financial Officer 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Merck Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merck Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Merck‘s full profile, request access.

Request a free trial

Merck Investments & Acquisitions (72)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 07-Jan-2021 000000000000000000 BPO/Outsource Services 0000000 00000000 00.0
0000000 00000000 14-Sep-2020 0000 000 Drug Discovery 00000 0000000000
000000000 11-Sep-2020 00000 00000 00 0000 Other Healthcare Technology Systems
000 000000 29-Jul-2020 00000 00000 00 0000 Biotechnology
Resolution Spectra Systems 01-Jul-2020 Merger/Acquisition Other Healthcare Technology Systems 000000 000000
You’re viewing 5 of 72 investments and acquisitions. Get the full list »

Merck Subsidiaries (21)

Company Name Industry Location Founded
ConnectMed Outcome Management (Healthcare) Kenya 2015
00000 0000000000 0 Accelerator/Incubator Darmstadt, Germany 0000
0000 00000000 Business/Productivity Software Darmstadt, Germany 0000
0000000000 0000000 Other Healthcare Technology Systems Meylan, France 0000
0 00000000 Corporate Venture Capital Amsterdam, Netherlands 0000
You’re viewing 5 of 21 subsidiaries. Get the full list »

Merck Exits (7)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 07-Sep-2012 000000000 00000 00 00000 Completed
  • 00000
0000000 0000000000 18-Jul-2008 00000 00000 00 0000 Completed
  • 4 buyers
00000000 11-Jun-2007 00000 00000 00 000.00 Completed
  • 00000
00000 00000000 000 08-Jun-2006 000000000 00000000 Completed
  • 00000
Prasfarma 15-Sep-2005 Merger/Acquisition 000.00 Completed
You’re viewing 5 of 7 exits. Get the full list »